TheraRadar
Data updated: May 26, 2026

PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE (phenylephrine hydrochloride)

Pain Approved 2006-12-07

PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE is indicated for the treatment of Cough; Nasal Congestion; Pain; Sore Throat; Headache; Runny Nose; Sneezing; Fever.

Source: FDA Label • Hikma
2
Indications
--
Phase 3 Trials
19
Years on Market

Details

Status
Discontinued
First Approved
2006-12-07
Routes
ORAL
Dosage Forms
SYRUP

PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE Approval History

2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Original
New Indication
New Form
Label Update
2 FDA actions from 2006 to 2014
Dec 2014 ORIGINAL
Update
Dec 2006 ORIGINAL
Update

What PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE Treats

8 indications

PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE is approved for 8 conditions since its original approval in 2006. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Cough
  • Nasal Congestion
  • Pain
  • Sore Throat
  • Headache
  • Runny Nose
  • Sneezing
  • Fever
Source: FDA Label

PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE Competitive Set

Pro

Three rings of competition based on shared molecular targets and treated indications.

Unlock 8 more competitors across all three rings.
Upgrade to Pro

Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.

Drugs Similar to PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE

3 of 20

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

IMMPHENTIV
PHENYLEPHRINE HYDROCHLORIDE
8 shared
Hikma
Shared indications:
CoughNasal CongestionPain +5 more
PHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
PHENYLEPHRINE HYDROCHLORIDE
8 shared
Dr. Reddy's
Shared indications:
CoughNasal CongestionPain +5 more
PROMETHAZINE W/ DEXTROMETHORPHAN
DEXTROMETHORPHAN HYDROBROMIDE
5 shared
PHARMOBEDIENT
Shared indications:
📋

Clinical Trial Registry

2 trials
Trial Sponsor ID Phase Status Title
NCT05997732 STARS Pro00126600 Ph 4 recruiting Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences
NCT03098680 PRIME PRIME (A094136) Ph 1 terminated A Study of the Pharmacokinetic and Pharmacodynamic Responses in Healthy and Altered Human Cardiovascular Systems
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE FDA Label Details

Indications & Usage

PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE is indicated for the treatment of Cough; Nasal Congestion; Pain; Sore Throat; Headache; Runny Nose; Sneezing; Fever.

Track PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE with TheraRadar Pro

Watchlist alerts, full database access, CSV exports across 14,000+ drugs.

Upgrade to Pro

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.